½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : ÄÄÆ÷³ÍÆ®º°, ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
Artificial Intelligence In Cardiology Market Size, Share & Trends Analysis Report By Component (Hardware, Services), By Application (Diagnosis, Prediction), By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå
:
1751298
¸®¼Ä¡»ç
:
Grand View Research, Inc.
¹ßÇàÀÏ
:
2025³â 05¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 120 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ
½ÉÀ庴Çпë ÀΰøÁö´É ¼¼°è ½ÃÀå ±Ô¸ð´Â 2030³â¿¡´Â 48¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2030³â CAGRÀº 22.81%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
½ÉÀåÁúȯÀÇ Áø´Ü ¹× Ä¡·á¸¦ À§ÇÑ ÀÇ·á ½Ã¼³ÀÇ ½Å±â¼ú äÅà Áõ°¡, Àü ¼¼°è ½ÉÇ÷°ü ÁúȯÀÇ ºÎ´ã Áõ°¡, ½ÉÀå ¿µ»ó Áø´ÜÀ» À§ÇÑ »õ·Î¿î ±â¼úÀ» Ãâ½ÃÇϱâ À§ÇÑ ½ÃÀå ÁøÃâ±â¾÷ °£ÀÇ °æÀï Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» Áö¿øÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù.
¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é ½ÉÇ÷°ü ÁúȯÀº Àü ¼¼°è ÁÖ¿ä »ç¸Á ¿øÀÎÀÔ´Ï´Ù. ¼¼°è½ÉÀ忬¸Í¿¡ µû¸£¸é ½ÉÇ÷°ü ÁúȯÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö´Â ÇâÈÄ ¼ö³â°£ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÉÀåÁúȯÀÇ ÁÖ¿ä ¿øÀÎÀ¸·Î´Â ½ºÆ®·¹½º, ÁÂ½Ä »ýȰ½À°ü, ÆÐ½ºÆ®Çªµå ¼·Ãë Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ¾É¾Æ¼ »ýȰÇÏ´Â Àα¸°¡ »ó´ç¼öÀ̱⠶§¹®¿¡ Áúº´ ºÎ´ãÀº ´õ¿í Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ¿¡ µû¶ó ½ÉÀå ÀÌ»óÀ» Á¤È®ÇÏ°Ô °¨ÁöÇÏ´Â ÀΰøÁö´É(AI) ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ÆÒµ¥¹Í ÀÌÈÄ ½ÃÀåÀÌ È°¼ºÈµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
³ëÈ´Â ½ÉÇ÷°ü ÁúȯÀÇ ÁÖ¿ä ¿øÀÎ Áß ÇϳªÀÔ´Ï´Ù. ±¹¸³º¸°Ç¿¬±¸¿ø¿¡ µû¸£¸é ³ëÈ´Â °ü»óµ¿¸ÆÁúȯ, ³úÁ¹Áß, ½ÉÀ帶ºñ, ±âŸ ½ÉÇ÷°üÁúȯ µî Áúº´ÀÇ ÁÖ¿ä ¿øÀÎ Áß ÇϳªÀ̸ç, WHO¿¡ µû¸£¸é 2020³â¿¡´Â 60¼¼ ÀÌ»ó ³ëÀÎÀÌ 10¾ï ¸íÀ» ³Ñ¾î¼³ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2050³â¿¡´Â 21¾ï ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ³ëÀÎ Àα¸ÀÇ ±Þ°ÝÇÑ Áõ°¡´Â ÀÌ·¯ÇÑ Áúº´ÀÇ ºÎ´ãÀ» Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµÇ¹Ç·Î ÇâÈÄ ¼ö³â°£ ½ÉÀåÁúȯÀ» ´õ ³ªÀº ¹æ½ÄÀ¸·Î Ä¡·áÇϱâ À§ÇÑ Ã·´Ü AI ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áö¿øÇÒ °ÍÀÔ´Ï´Ù.
ÀΰøÁö´ÉÀº ½ÉÇ÷°ü ÁúȯÀÇ Áø´Ü Á¤È®µµ¸¦ Çâ»ó½ÃŰ°í °ÈÇϰí ÀÖ½À´Ï´Ù. ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÇ °³¹ßÀÌ Á¡Á¡ ´õ ¹ßÀüÇÏ¿© ½ÉºÎÀü, ½ÉÀåÆÇ¸·Áõ, °ü»óµ¿¸ÆÁúȯ µîÀÇ Áø´Ü°ú Ä¡·á¿¡ ³Î¸® Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀ» ÀÌ¿ëÇÑ Áø´Ü ¹× ¿¹ÈÄ ¿¹Ãø ´É·ÂÀÇ Çâ»óÀº ½ÉÇ÷°ü Áúȯ ȯÀÚÀÇ ÀÓ»ó Ä¡·á¸¦ °ÈÇϰí ÀÖ½À´Ï´Ù. ¸¹Àº ¿¬±¸¿¡¼ ÀΰøÁö´ÉÀº 80% ÀÌ»óÀÇ Á¤È®µµ·Î ½ÉÀå ÀÌ»óÀ» °¨ÁöÇÏ´Â °ÍÀ¸·Î º¸°íµÇ°í ÀÖ½À´Ï´Ù. À§ÀÇ ¸ðµç ¿äÀÎÀº ½ÉÀ庴Çпë ÀΰøÁö´É ¼ö¿ä¸¦ Áõ°¡½Ãų °¡´É¼ºÀÌ ³ô½À´Ï´Ù.
½ÉÀ庴ÇÐ ºÐ¾ß ÀΰøÁö´É ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- Çϵå¿þ¾î ±â±â ºÎ¹®Àº Áø´Ü ¹× Ä¡·á Á¤È®µµ Çâ»óÀ¸·Î ÀÎÇØ 2024³â 36.66%ÀÇ ÃÖ´ë ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» ¼±µµÇß½À´Ï´Ù.
- Áø´Ü ºÎ¹®Àº 2024³â 39.94%ÀÇ ÃÖ´ë ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
- ÇãÇ÷¼º ½ÉÀåÁúȯ(IHD)/CAD ºÎ¹®Àº 2024³â 37.93%ÀÇ ÃÖ´ë ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» ¼±µµÇß½À´Ï´Ù.
- ºÏ¹Ì°¡ 2024³â 45.00%ÀÇ ÃÖ´ë ¸ÅÃâ Á¡À¯À²·Î ½ÉÀåÇÐ ºÐ¾ß ÀΰøÁö´É ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå °³¿ä
Á¦3Àå ½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- ½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- ½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀå ºÐ¼® Åø : PorterÀÇ »ê¾÷ ºÐ¼®
- ¿äÀκ° SWOT ºÐ¼®(Á¤Ä¡¡¤¹ý·ü, °æÁ¦, »çȸ, ±â¼ú)
- COVID-19ÀÇ ¿µÇâ
Á¦4Àå ½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀå : ÄÄÆ÷³ÍÆ®º°, ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀå : ÄÄÆ÷³ÍÆ® ºÐ¼®, 2023³â°ú 2030³â
- ½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀå, ÄÄÆ÷³ÍÆ®º°, 2018-2030³â
- ¼ÒÇÁÆ®¿þ¾î
- Çϵå¿þ¾î
- ¼ºñ½º
Á¦5Àå ½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀå : ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀå : ¿ëµµ ºÐ¼®, 2023³â°ú 2030³â
- ½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀå, ¿ëµµº°, 2018-2030³â
- Áø´Ü
- ¿¹Ãø
- Drug Discovery
- ±âŸ
Á¦6Àå ½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀå : º´»óº°, ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀå : º´»ó ºÐ¼®, 2023³â°ú 2030³â
- ½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀå, º´»óº°, 2018-2030³â
- ºÎÁ¤¸Æ
- ½ÉºÎÀü
- ÇãÇ÷¼º ½ÉÁúȯ/CAD
- ±âŸ
Á¦7Àå ½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀå : Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®
- ½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀå Á¡À¯À²(Áö¿ªº°, 2023³â°ú 2030³â, 100¸¸ ´Þ·¯)
- ºÏ¹Ì
- ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
- ¹Ì±¹
- ij³ª´Ù
- À¯·´
- ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ½º¿þµ§
- µ§¸¶Å©
- ³ë¸£¿þÀÌ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
- ÀϺ»
- Áß±¹
- Àεµ
- È£ÁÖ
- ű¹
- Çѱ¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- ¸ß½ÃÄÚ
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
- Äí¿þÀÌÆ®
Á¦8Àå ½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀå : °æÀï ºÐ¼®
- ÁÖ¿ä ½ÃÀå Âü¿© ±â¾÷¿¡ ÀÇÇÑ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
- ±â¾÷ ºÐ·ù
- ±â¾÷ÀÇ ½ÃÀå ÇöȲ ºÐ¼®
Á¦9Àå ½ÉÀ庴Çпë ÀΰøÁö´É ½ÃÀå : °æÀï ±¸µµ
- ÁÖ¿ä ½ÃÀå Âü¿© ±â¾÷¿¡ ÀÇÇÑ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
- ±â¾÷/°æÀï ºÐ·ù
- ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À²/Æ÷Áö¼Ç ºÐ¼®, 2023³â
- ±â¾÷ °³¿ä
KSA
¿µ¹® ¸ñÂ÷
Artificial intelligence In Cardiology Market Growth & Trends:
The global artificial intelligence in cardiology market size is expected to reach USD 4.84 billion in 2030 and is projected to grow at a CAGR of 22.81% from 2025 to 2030. The increase in the adoption of new technologies by healthcare facilities for the diagnosis and treatment of cardiac diseases, the growing burden of cardiovascular diseases worldwide, and increasing competition among market players to launch new technologies for cardiac imaging are some of the major factors supporting the market's growth.
According to the WHO, cardiovascular diseases are a major cause of death worldwide. The World Heart Federation states that cardiovascular deaths are expected to rise in the coming years. i.e., from 18.9 million in 2020 to 32.3 million in 2050. Some major causes of cardiac diseases are stress, sedentary lifestyles, and an increase in the consumption of fast food, among others. A significant number of people adopting a sedentary lifestyle is expected to increase the disease burden further. This is expected to improve the demand for artificial intelligence (AI) technology to accurately detect cardiac abnormalities and thus boost the market in the post-pandemic period.
Aging is one of the major causes of cardiovascular diseases. According to the National Institute of Health, aging is one of the major reasons for diseases such as coronary artery disease, stroke, heart attack, and other cardiovascular diseases. According to the WHO, in 2020, over 1 billion people were aged 60 years and above, and by 2050, this number is expected to rise to 2.1 billion. The surge in the geriatric population is expected to increase the burden of these diseases and thus support the demand for advanced AI technology in the coming years for treating heart diseases in a better way.
Artificial intelligence has improved and enhanced the accuracy of diagnosing cardiovascular diseases. Machine learning algorithms are increasingly being developed and are widely used in the diagnosis and treatment of heart failure, valvular heart disease, and coronary artery disease, among others. Improved diagnostic and prognostic capabilities using machine learning algorithms are enhancing the clinical care of patients suffering from cardiovascular diseases. Many studies have reported that artificial intelligence detects abnormalities in the heart with more than 80% accuracy. All the above-mentioned factors are likely to boost the demand for AI in cardiology.
Artificial Intelligence In Cardiology Market Report Highlights:
- The hardware devices segment led the market with the largest revenue share of 36.66% in 2024, by offering enhanced diagnostic accuracy and treatment precision.
- The diagnosis segment led the market with the largest revenue share of 39.94% in 2024.
- The ischemic heart disease (IHD)/CAD segment led the market with the largest revenue share of 37.93% in 2024.
- North America dominated the AI in cardiology market with the largest revenue share of 45.00% in 2024.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation and Scope
- 1.1.1 Segment Definition
- 1.1.1.1 Component type segment
- 1.1.1.2 Application segment
- 1.1.1.3 Medical condition segment
- 1.2 Regional Scope
- 1.2.1 Estimates And Forecast Timeline
- 1.3 Objectives
- 1.3.1 Objective - 1
- 1.3.2 Objective - 2
- 1.3.3 Objective - 3
- 1.4 Research Methodology
- 1.5 Information Procurement
- 1.6 Market-specific Research Models
- 1.6.1 Consensus-based estimates & forecasting
- 1.6.2 Model 1: Commodity Flow Analysis
- 1.6.2.1 List of some notable companies considered for commodity flow analysis
- 1.6.3 Model 2: Parent Market Analysis
- 1.6.4 Model 3: Country-Level Multivariate Analysis Assumptions
- 1.6.5 Model 4: Segment-Level Multivariate Analysis Assumptions
- 1.6.5.1 Global Segment-Level Multivariate Analysis: Component Type
- 1.6.5.2 Global Segment-Level Multivariate Analysis: Medical Condition Type
- 1.6.6 Ai In Cardiology Market Cagr Calculation
- 1.6.7 Other Variables Considered In The Market Analysis
- 1.6.7.1 Variable/Metrics 1 - Internet Penetration (% Of The Population)
- 1.6.7.2 Variable/Metrics 2 - AI Adoption Index
- 1.7 List of Secondary Sources
Chapter 2 Executive Summary
- 2.1 AI in Cardiology Market Snapshot
- 2.2 AI in Cardiology Market Segment Snapshot (Part 1)
- 2.3 AI in Cardiology Market Segment Snapshot (Part 2)
- 2.4 AI in Cardiology Market Competitive Landscape Snapshot
Chapter 3 AI in Cardiology Market Variables, Trends, & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.2 Ai In Cardiology Market Dynamics
- 3.2.1 Market Driver Analysis
- 3.2.1.1 Growing Burden Of Cardiovascular Diseases And The Need For Efficient Healthcare Solutions
- 3.2.1.2 Increasing Strategic Initiatives In Ai Technologies
- 3.2.1.3 Technological Advancements In Ai Algorithms And Imaging Techniques
- 3.2.2 Market Restraint Analysis
- 3.2.2.1 Regulatory Challenges And Ethical Considerations
- 3.2.2.2 High Implementation And Procurement Costs
- 3.2.2.3 Lack Of Skilled Labor Having Knowledge Related To Technology
- 3.3 Ai In Cardiology Market Analysis Tools: Porters
- 3.4 SWOT Analysis by Factors (Political & Legal, Economic, Social, and Technology)
- 3.5 COVID-19 Impact
Chapter 4 AI in Cardiology Market: Component Estimates & Trend Analysis
- 4.1 Segment Dashboard
- 4.2 Artificial Intelligence in Cardiology Market: Component Analysis, 2023 & 2030 (USD Million)
- 4.3 Artificial Intelligence in Cardiology Market, by Component, 2018 - 2030 (USD Million)
- 4.4 Software
- 4.4.1 Software Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.5 Hardware
- 4.5.1 Hardware Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.6 Services
- 4.6.1 Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 5 Artificial Intelligence in Cardiology Market: Application Estimates & Trend Analysis
- 5.1 Segment Dashboard
- 5.2 Artificial Intelligence In Cardiology Market: Application Analysis, 2023 & 2030 (USD Million)
- 5.3 Artificial Intelligence In Cardiology Market, By Application, 2018 - 2030 (USD Million)
- 5.4 Diagnosis
- 5.4.1 Diagnosis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 5.5 Prediction
- 5.5.1 Prediction Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 5.6 Drug Discovery
- 5.6.1 Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 5.7 Others
- 5.7.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 6 Artificial Intelligence in Cardiology Market: Medical Condition Estimates & Trend Analysis
- 6.1 Segment Dashboard
- 6.2 Artificial Intelligence In Cardiology Market: Medical Condition Analysis, 2023 & 2030 (USD Million)
- 6.3 Artificial Intelligence In Cardiology Market, By Medical Condition, 2018 - 2030 (USD Million)
- 6.4 Cardiac Arrhythmias
- 6.4.1 Cardiac Arrhythmias Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5 Heart Failure
- 6.5.1 Heart Failure Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6 Ischemic Heart Disease/Cad
- 6.6.1 Ischemic Heart Disease/Cad Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.7 Others
- 6.7.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7 AI in Cardiology Market: Regional Estimates & Trend Analysis
- 7.1 AI in Cardiology Market Share, by Region, 2023 & 2030, USD Million
- 7.2 North America
- 7.2.1 Regulatory Framework
- 7.2.2 North America Artificial Intelligence In Cardiology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.2.3 U.S.
- 7.2.3.1 U.S. Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.2.4 CANADA
- 7.2.4.1 Canada Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3 Europe
- 7.3.1 Regulatory Framework
- 7.3.2 Europe Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.3 UK
- 7.3.3.1 UK Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.4 Germany
- 7.3.4.1 Germany Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.5 France
- 7.3.5.1 France Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.6 Italy
- 7.3.6.1 Italy Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.7 Spain
- 7.3.7.1 SPAIN Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.8 Sweden
- 7.3.8.1 Sweden Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.9 Denmark
- 7.3.9.1 Denmark Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.10 Norway
- 7.3.10.1 Norway Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4 Asia Pacific
- 7.4.1 Regulatory Framework
- 7.4.2 Asia Pacific Artificial Intelligence In cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.3 Japan
- 7.4.3.1 Japan Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.4 China
- 7.4.4.1 China Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.5 India
- 7.4.5.1 India Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.6 Australia
- 7.4.6.1 Australia Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.7 Thailand
- 7.4.7.1 Thailand Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.8 South Korea
- 7.4.8.1 South Korea Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5 Latin America
- 7.5.1 Regulatory Framework
- 7.5.2 Latin America Artificial Intelligence In cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.3 Brazil
- 7.5.3.1 Brazil Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.4 Argentina
- 7.5.4.1 Argentina Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.5 Mexico
- 7.5.5.1 Mexico Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6 Middle East & Africa
- 7.6.1 Regulatory Framework
- 7.6.2 MEA Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.3 SOUTH AFRICA
- 7.6.3.1 South Africa Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.4 SAUDI ARABIA
- 7.6.4.1 Saudi Arabia Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.5 UAE
- 7.6.5.1 UAE Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.6 KUWAIT
- 7.6.6.1 Kuwait Artificial Intelligence in cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8 AI in Cardiology Market: Competitive Analysis
- 8.1 Recent Developments & Impact Analysis, by Key Market Participants
- 8.2 Company Categorization
- 8.3 Company Market Position Analysis
Chapter 9 AI in Cardiology Market: Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.3. Key company market share/position analysis, 2023
- 9.4. Company Profiles
- 9.4.1. IDOVEN
- 9.4.1.1. Company overview
- 9.4.1.2. Financial performance
- 9.4.1.3. Technology Type benchmarking
- 9.4.1.4. Strategic initiatives
- 9.4.2. CardiAI
- 9.4.2.1. Company overview
- 9.4.2.2. Financial performance
- 9.4.2.3. Technology Type benchmarking
- 9.4.2.4. Strategic initiatives
- 9.4.3. Ultromics Limited
- 9.4.3.1. Company overview
- 9.4.3.2. Financial performance
- 9.4.3.3. Technology Type benchmarking
- 9.4.3.4. Strategic initiatives
- 9.4.4. Arterys Inc. (Tempus)
- 9.4.4.1. Company overview
- 9.4.4.2. Financial performance
- 9.4.4.3. Technology Type benchmarking
- 9.4.4.4. Strategic initiatives
- 9.4.5. Cardiologs (Koninklijke Philips N.V.)
- 9.4.5.1. Company overview
- 9.4.5.2. Financial performance
- 9.4.5.3. Technology Type benchmarking
- 9.4.5.4. Strategic initiatives
- 9.4.6. Ultrasight
- 9.4.6.1. Company overview
- 9.4.6.2. Financial performance
- 9.4.6.3. Technology Type benchmarking
- 9.4.6.4. Strategic initiatives
- 9.4.7. DiA Imaging Analysis (Koninklijke Philips N.V.)
- 9.4.7.1. Company overview
- 9.4.7.2. Financial performance
- 9.4.7.3. Technology Type benchmarking
- 9.4.7.4. Strategic initiatives
- 9.4.8. Vista AI
- 9.4.8.1. Company overview
- 9.4.8.2. Financial performance
- 9.4.8.3. Technology Type benchmarking
- 9.4.8.4. Strategic initiatives
- 9.4.9. Viz ai
- 9.4.9.1. Company overview
- 9.4.9.2. Financial performance
- 9.4.9.3. Technology Type benchmarking
- 9.4.9.4. Strategic initiatives
- 9.4.10. RSIP Vision
- 9.4.10.1. Company overview
- 9.4.10.2. Financial performance
- 9.4.10.3. Technology Type benchmarking
- 9.4.10.4. Strategic initiatives
- 9.4.11. Cleerly, Inc.
- 9.4.11.1. Company overview
- 9.4.11.2. Financial performance
- 9.4.11.3. Technology Type benchmarking
- 9.4.11.4. Strategic initiatives
°ü·ÃÀÚ·á